Vitaresp M 10mg Tablet
By Vitaresp M
Rx
10 Tablet in a Strip

Composition
Montelukast(10mg)

Manufacturer - Alembic Pharmaceuticals Ltd
Alembic Road, Vadodara - 390 003, Gujarat,INDIA

Expires on or after
October, 2025

liver
When using Vitaresp M 10mg Tablet, it is important to exercise caution if you have severe liver disease. In such cases, dose adjustment may be required, and it is recommended to consult your doctor before taking this medication. Limited information is currently available regarding the use of Vitaresp M 10mg Tablet in patients with severe liver disease. However, if you have mild to moderate liver disease, no dose adjustment is typically necessary. Be sure to follow your healthcare provider's guidance and seek their advice for the best approach to managing your condition while using Vitaresp M 10mg Tablet.

kidney
Vitaresp M 10mg Tablet is safe for patients with kidney disease. No dose adjustment is needed for this medication.

alcohol
When taking Vitaresp M 10mg Tablet, it is advisable to be cautious when consuming alcohol. It is recommended to consult your doctor.

driving
Vitaresp M 10mg Tablet may reduce alertness, affect vision, and cause drowsiness or dizziness. Refrain from driving if experiencing these symptoms.

pregnancy
Vitaresp M 10mg Tablet is generally safe during pregnancy, based on animal studies. Limited human studies are available; consult your doctor for advice.

breastfeeding
Vitaresp M 10mg Tablet is considered safe during breastfeeding based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | 1,3-Diarylpropanoid Derivative |
Therapeutic Class | RESPIRATORY |
Action Class | Leukotriene antagonists |
₹125.13
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024